UPC Analytics
ENDE
Overview · Filed: Jan 13, 2025

UPC_CFI_18/2025

VARIANTS OF C-TYPE NATRIURETIC PEPTIDE

InfringementMain Infringement ActionMunich LDInfringementCase Closed
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • BioMarin Pharmaceutical Inc.

Respondents

  • Ascendis Pharma A/S
  • Ascendis Pharma Growth Disorders A/S
Judges
  • Matthias Zigann
  • Andras Kupecz
  • Tobias Pichlmaier
  • Eric André Enderlin
Patents
  • EP3175863
CPC codes: A61K47/26, G01N2800/52, A61P9/00, A61K47/20, C12N15/70, A61K9/08, A61K47/60, A61K47/10, C07K14/58, G01N2800/105, A61K38/2242, A61K9/19…

Technology area: Biotech · Peptide Therapeutics

Sector: Biotechnology

Outcome
—
Filed: Jan 13, 2025
First decided: —
Language: English
Open on UPC Registry